These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 20587623

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression.
    Sugatani J, Wada T, Osabe M, Yamakawa K, Yoshinari K, Miwa M.
    Drug Metab Dispos; 2006 Oct; 34(10):1677-87. PubMed ID: 16815962
    [Abstract] [Full Text] [Related]

  • 4. Deteriorating effect of fluvastatin on the cholestatic liver injury induced by bile duct ligation in rats.
    Lotková H, Staňková P, Roušar T, Kučera O, Kohoutek L, Mičuda S, Brčáková E, Kolouchová G, Cervinková Z.
    Gen Physiol Biophys; 2011 Mar; 30(1):66-74. PubMed ID: 21460414
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic drug interaction between fexofenadine and fluvastatin mediated by organic anion-transporting polypeptides in rats.
    Qiang F, Lee BJ, Lee W, Han HK.
    Eur J Pharm Sci; 2009 Jun 28; 37(3-4):413-7. PubMed ID: 19428223
    [Abstract] [Full Text] [Related]

  • 6. Steady-state pharmacokinetics of fluvastatin in healthy subjects following a new extended release fluvastatin tablet, Lescol XL.
    Barilla D, Prasad P, Hubert M, Gumbhir-Shah K.
    Biopharm Drug Dispos; 2004 Mar 28; 25(2):51-9. PubMed ID: 14872552
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of clopidogrel on the steady-state pharmacokinetics of fluvastatin.
    Ayalasomayajula SP, Vaidyanathan S, Kemp C, Prasad P, Balch A, Dole WP.
    J Clin Pharmacol; 2007 May 28; 47(5):613-9. PubMed ID: 17442686
    [Abstract] [Full Text] [Related]

  • 9. SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin.
    Niemi M, Pasanen MK, Neuvonen PJ.
    Clin Pharmacol Ther; 2006 Oct 28; 80(4):356-66. PubMed ID: 17015053
    [Abstract] [Full Text] [Related]

  • 10. Updated clinical safety experience with fluvastatin.
    Jokubaitis LA.
    Am J Cardiol; 1994 May 26; 73(14):18D-24D. PubMed ID: 8198019
    [Abstract] [Full Text] [Related]

  • 11. Drug-Induced Acute Liver Injury Within 12 Hours After Fluvastatin Therapy.
    Li L, Ma Y, Geng XB, Song YX, Tan Z, Shang XM, Zhao GY, Zhao BQ, Tian MR.
    Am J Ther; 2016 May 26; 23(1):e318-20. PubMed ID: 24451297
    [Abstract] [Full Text] [Related]

  • 12. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
    Conforti A, Magro L, Moretti U, Scotto S, Motola D, Salvo F, Ros B, Leone R.
    Drug Saf; 2006 May 26; 29(12):1163-72. PubMed ID: 17147462
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Involvement of organic anion transporting polypeptides in the toxicity of hydrophilic pravastatin and lipophilic fluvastatin in rat skeletal myofibres.
    Sakamoto K, Mikami H, Kimura J.
    Br J Pharmacol; 2008 Aug 26; 154(7):1482-90. PubMed ID: 18500364
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of fluvastatin in subjects with renal impairment and nephrotic syndrome.
    Appel-Dingemanse S, Smith T, Merz M.
    J Clin Pharmacol; 2002 Mar 26; 42(3):312-8. PubMed ID: 11865968
    [Abstract] [Full Text] [Related]

  • 17. Fluvastatin, rhabdomyolysis, and myotoxicity.
    Murinson BB, Maragakis NJ, Jacobson TA.
    Mayo Clin Proc; 2008 Nov 26; 83(11):1296; author reply 1297. PubMed ID: 18990330
    [No Abstract] [Full Text] [Related]

  • 18. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
    Noé J, Portmann R, Brun ME, Funk C.
    Drug Metab Dispos; 2007 Aug 26; 35(8):1308-14. PubMed ID: 17470528
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The difference in pharmacokinetics and pharmacodynamics between extended-release fluvastatin and immediate-release fluvastatin in healthy Chinese subjects.
    Xu HR, Chen WL, Chu NN, Li XN, Zhu JR.
    J Biomed Biotechnol; 2012 Aug 26; 2012():386230. PubMed ID: 22811596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.